The Role of Mesenchymal Stem Cells in Liver Regeneration
DOI:
https://doi.org/10.58427/apghn.2.3.2023.39-51Keywords:
mesenchymal stem cells, liver regeneration, fibrosisAbstract
Background: Inflammation of the liver caused by cholestasis, viral infection, alcohol, autoimmune reactions, toxins, or metabolism will result in a prolonged immune response. As a result, simultaneous inflammation and tissue remodelling occur, resulting in fibrosis and eventually leading to cirrhosis. The main treatment for end-stage liver cirrhosis is liver transplantation. However, it is often not possible for patients to undergo this life-saving procedure. On the other hand, stem cell transplantation may be a potential strategy to prevent disease progression and improve the degree of fibrosis.
Discussion: Inflammation of the liver activates hepatic stellate cells, which are perisinusoidal cells in the Disse cavity that contain vitamin A. Hepatic stellate cells activation results in retinoid storage loss and transformation into myofibroblast-like cells that express α-smooth muscle action (α-SMA) and produce collagen which plays a major role in fibrosis. Liver regeneration due to chronic liver damage is played by mesenchymal cells through the mesenchymal-epithelial or epithelial-mesenchymal transition (MET/EMT) process. Administration by the intrahepatic route is thought to be the ideal route because fewer cells are lost in the circulation and more mesenchymal stem cells differentiates into hepatocytes in the damaged liver area. However, intrasplenic route maybe an alternative with easier administration technique. There are special considerations regarding the risks, including the risk of carcinogenesis and viral transmission.
Conclusion: Mesenchymal stem cells transplantation may be a potential therapeutic strategy for patients with end stage liver disease in the future. However, future research is needed regarding the risk of carcinogenesis and viral transmission following the procedure.
References
Issa R, Williams E, Trim N, Kendall T, Arthur MJ, Reichen J, et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut. 2001;48(4):548-57.https://doi.org/10.1136/gut.48.4.548 DOI: https://doi.org/10.1136/gut.48.4.548
Tanaka M, Miyajima A. Liver regeneration and fibrosis after inflammation. Inflamm Regen. 2016;36:19.https://doi.org/10.1186/s41232-016-0025-2 DOI: https://doi.org/10.1186/s41232-016-0025-2
Cordero-Espinoza L, Huch M. The balancing act of the liver: tissue regeneration versus fibrosis. J Clin Invest. 2018;128(1):85-96.https://doi.org/10.1172/jci93562 DOI: https://doi.org/10.1172/JCI93562
Ramachandran P, Iredale JP. Liver fibrosis: a bidirectional model of fibrogenesis and resolution. Qjm. 2012;105(9):813-7.https://doi.org/10.1093/qjmed/hcs069 DOI: https://doi.org/10.1093/qjmed/hcs069
Dooley S, ten Dijke P. TGF-β in progression of liver disease. Cell Tissue Res. 2012;347(1):245-56.https://doi.org/10.1007/s00441-011-1246-y DOI: https://doi.org/10.1007/s00441-011-1246-y
Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology. 2013;58(4):1461-73.https://doi.org/10.1002/hep.26429 DOI: https://doi.org/10.1002/hep.26429
Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver. 2020;14(3):306-15.https://doi.org/10.5009/gnl18412 DOI: https://doi.org/10.5009/gnl18412
Zhang Y, Li Y, Zhang L, Li J, Zhu C. Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis. Stem Cell Research & Therapy. 2018;9(1):59.https://doi.org/10.1186/s13287-018-0814-4 DOI: https://doi.org/10.1186/s13287-018-0814-4
Ishii T, Yasuchika K, Machimoto T, Kamo N, Komori J, Konishi S, et al. Transplantation of embryonic stem cell-derived endodermal cells into mice with induced lethal liver damage. Stem Cells. 2007;25(12):3252-60.https://doi.org/10.1634/stemcells.2007-0199 DOI: https://doi.org/10.1634/stemcells.2007-0199
Xie G, Diehl AM. Evidence for and against epithelial-to-mesenchymal transition in the liver. Am J Physiol Gastrointest Liver Physiol. 2013;305(12):G881-90.https://doi.org/10.1152/ajpgi.00289.2013 DOI: https://doi.org/10.1152/ajpgi.00289.2013
Choi SS, Diehl AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology. 2009;50(6):2007-13.https://doi.org/10.1002/hep.23196 DOI: https://doi.org/10.1002/hep.23196
Li Q, Hutchins AP, Chen Y, Li S, Shan Y, Liao B, et al. A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes. Nat Commun. 2017;8:15166.https://doi.org/10.1038/ncomms15166
Jang YO, Kim MY, Cho MY, Baik SK, Cho YZ, Kwon SO. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model. BMC Gastroenterol. 2014;14:198.https://doi.org/10.1186/s12876-014-0198-6 DOI: https://doi.org/10.1186/s12876-014-0198-6
Cao Y, Ji C, Lu L. Mesenchymal stem cell therapy for liver fibrosis/cirrhosis. Ann Transl Med. 2020;8(8):562.https://doi.org/10.21037/atm.2020.02.119 DOI: https://doi.org/10.21037/atm.2020.02.119
Xu L, Gong Y, Wang B, Shi K, Hou Y, Wang L, et al. Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells. J Gastroenterol Hepatol. 2014;29(8):1620-8.https://doi.org/10.1111/jgh.12653 DOI: https://doi.org/10.1111/jgh.12653
El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev Rep. 2012;8(3):972-81.https://doi.org/10.1007/s12015-011-9322-y DOI: https://doi.org/10.1007/s12015-011-9322-y
Wang L, Li J, Liu H, Li Y, Fu J, Sun Y, et al. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28 Suppl 1:85-92.https://doi.org/10.1111/jgh.12029 DOI: https://doi.org/10.1111/jgh.12029
Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27 Suppl 2:112-20.https://doi.org/10.1111/j.1440-1746.2011.07024.x DOI: https://doi.org/10.1111/j.1440-1746.2011.07024.x
di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut. 2008;57(2):223-31.https://doi.org/10.1136/gut.2006.111617 DOI: https://doi.org/10.1136/gut.2006.111617
Coppin L, Sokal E, Stéphenne X. Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives. Cells. 2019;8(10).https://doi.org/10.3390/cells8101160 DOI: https://doi.org/10.3390/cells8101160
Coppin LCF, Smets F, Ambroise J, Sokal EEM, Stéphenne X. Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders. Stem Cell Research & Therapy. 2020;11(1):51.https://doi.org/10.1186/s13287-020-1572-7 DOI: https://doi.org/10.1186/s13287-020-1572-7
Yang X, Meng Y, Han Z, Ye F, Wei L, Zong C. Mesenchymal stem cell therapy for liver disease: full of chances and challenges. Cell Biosci. 2020;10:123.https://doi.org/10.1186/s13578-020-00480-6 DOI: https://doi.org/10.1186/s13578-020-00480-6
Amer ME, El-Sayed SZ, El-Kheir WA, Gabr H, Gomaa AA, El-Noomani N, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011;23(10):936-41.https://doi.org/10.1097/MEG.0b013e3283488b00 DOI: https://doi.org/10.1097/MEG.0b013e3283488b00
Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109(10):1291-302.https://doi.org/10.1172/jci15182 DOI: https://doi.org/10.1172/JCI0215182
Ong SY, Dai H, Leong KW. Inducing hepatic differentiation of human mesenchymal stem cells in pellet culture. Biomaterials. 2006;27(22):4087-97.https://doi.org/10.1016/j.biomaterials.2006.03.022 DOI: https://doi.org/10.1016/j.biomaterials.2006.03.022
Lange C, Bassler P, Lioznov MV, Bruns H, Kluth D, Zander AR, et al. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol. 2005;11(29):4497-504.https://doi.org/10.3748/wjg.v11.i29.4497 DOI: https://doi.org/10.3748/wjg.v11.i29.4497
Dai L-J, Li HY, Guan L-X, Ritchie G, Zhou JX. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Research. 2009;2(1):16-25.https://doi.org/https://doi.org/10.1016/j.scr.2008.07.005 DOI: https://doi.org/10.1016/j.scr.2008.07.005
Manousou P, Arvaniti V, Tsochatzis E, Isgro G, Jones K, Shirling G, et al. Primary biliary cirrhosis after liver transplantation: influence of immunosuppression and human leukocyte antigen locus disparity. Liver Transpl. 2010;16(1):64-73.https://doi.org/10.1002/lt.21960 DOI: https://doi.org/10.1002/lt.21960
Kisseleva T, Brenner DA. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. Journal of Hepatology. 2012;56(4):965-72.https://doi.org/https://doi.org/10.1016/j.jhep.2011.09.021 DOI: https://doi.org/10.1016/j.jhep.2011.09.021
Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54(5):1418-37.https://doi.org/10.1111/trf.12421 DOI: https://doi.org/10.1111/trf.12421
Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141-50.https://doi.org/10.1016/j.stem.2007.11.014 DOI: https://doi.org/10.1016/j.stem.2007.11.014
Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105(7):2821-7.https://doi.org/10.1182/blood-2004-09-3696 DOI: https://doi.org/10.1182/blood-2004-09-3696
Lee KC, Lin HC, Huang YH, Hung SC. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. J Hepatol. 2015;63(6):1405-12.https://doi.org/10.1016/j.jhep.2015.07.035 DOI: https://doi.org/10.1016/j.jhep.2015.07.035
Wang J, Bian C, Liao L, Zhu Y, Li J, Zeng L, et al. Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms. Hepatol Res. 2009;39(12):1219-28.https://doi.org/10.1111/j.1872-034X.2009.00564.x DOI: https://doi.org/10.1111/j.1872-034X.2009.00564.x
Rabani V, Shahsavani M, Gharavi M, Piryaei A, Azhdari Z, Baharvand H. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int. 2010;34(6):601-5.https://doi.org/10.1042/cbi20090386 DOI: https://doi.org/10.1042/CBI20090386
Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007;363(2):247-52.https://doi.org/10.1016/j.bbrc.2007.05.150 DOI: https://doi.org/10.1016/j.bbrc.2007.05.150
Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, et al. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res. 2008;68(11):4331-9.https://doi.org/10.1158/0008-5472.Can-08-0943 DOI: https://doi.org/10.1158/0008-5472.CAN-08-0943
Li Q, Hutchins AP, Chen Y, Li S, Shan Y, Liao B, et al. A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes. Nature Communications. 2017;8(1):15166.https://doi.org/10.1038/ncomms15166 DOI: https://doi.org/10.1038/ncomms15166
Lala V, Zubair M, Minter DA. Liver function tests. StatPearls [internet]: StatPearls Publishing; 2022.
Lo RC, Kim H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017;23(4):302-7.https://doi.org/10.3350/cmh.2017.0078 DOI: https://doi.org/10.3350/cmh.2017.0078
Kim MY, Cho MY, Baik SK, Park HJ, Jeon HK, Im CK, et al. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol. 2011;55(5):1004-9.https://doi.org/10.1016/j.jhep.2011.02.012 DOI: https://doi.org/10.1016/j.jhep.2011.02.012
Mohammed FF, Khokha R. Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol. 2005;15(10):555-63.https://doi.org/10.1016/j.tcb.2005.08.009 DOI: https://doi.org/10.1016/j.tcb.2005.08.009
Hoffmann K, Nagel AJ, Tanabe K, Fuchs J, Dehlke K, Ghamarnejad O, et al. Markers of liver regeneration—the role of growth factors and cytokines: a systematic review. BMC Surgery. 2020;20(1):31.https://doi.org/10.1186/s12893-019-0664-8 DOI: https://doi.org/10.1186/s12893-019-0664-8
Sasturkar SV, David P, Sharma S, Sarin SK, Trehanpati N, Pamecha V. Serial changes of cytokines and growth factors in peripheral circulation after right lobe donor hepatectomy. Liver Transpl. 2016;22(3):344-51.https://doi.org/10.1002/lt.24373 DOI: https://doi.org/10.1002/lt.24373
Aryal B, Shimizu T, Kadono J, Furoi A, Komokata T, Inoue M, et al. A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans. PLoS One. 2016;11(3):e0150446.https://doi.org/10.1371/journal.pone.0150446 DOI: https://doi.org/10.1371/journal.pone.0150446
Liu J, Hu X, Chen J, Li X, Wang L, Wang B, et al. Pericentral hepatocytes produce insulin-like growth factor-2 to promote liver regeneration during selected injuries in mice. Hepatology. 2017;66(6):2002-15.https://doi.org/10.1002/hep.29340 DOI: https://doi.org/10.1002/hep.29340
Wang R, Huebert RC, Shah VH. Sinusoidal endothelial cells coordinate liver regeneration and angiogenesis via angiopoietin-2: an ode to prometheus. Gastroenterology. 2014;147(2):533-4.https://doi.org/10.1053/j.gastro.2014.06.015 DOI: https://doi.org/10.1053/j.gastro.2014.06.015
Awuah PK, Nejak-Bowen KN, Monga SP. Role and regulation of PDGFRα signaling in liver development and regeneration. Am J Pathol. 2013;182(5):1648-58.https://doi.org/10.1016/j.ajpath.2013.01.047 DOI: https://doi.org/10.1016/j.ajpath.2013.01.047
Nygård IE, Mortensen KE, Hedegaard J, Conley LN, Bendixen C, Sveinbjørnsson B, et al. Tissue Remodelling following Resection of Porcine Liver. Biomed Res Int. 2015;2015:248920.https://doi.org/10.1155/2015/248920 DOI: https://doi.org/10.1155/2015/248920
Pawitan JA, Leviana M, Sukmawati D, Liem IK, Margiana R, Tarcisia T. Prospect of umbilical cord mesenchymal stem cell culture waste in regenerative medicine. J Global Pharma Technol. 2017;9(7):1-5
Published
Issue
Section
License
Copyright (c) 2023 Hardian Gunardi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
